Tyra Biosciences Inc (NASDAQ: TYRA) established initial surge of 26.35% at $21.0, as the Stock market unbolted on Thursday, before settling in for the price of $16.62 at the close. Taking a more long-term approach, TYRA posted a 52-week range of $6.42-$17.27.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -73.69%. Meanwhile, its Annual Earning per share during the time was -73.69%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -32.45%. This publicly-traded company’s shares outstanding now amounts to $53.32 million, simultaneously with a float of $35.09 million. The organization now has a market capitalization sitting at $1.12 billion. At the time of writing, stock’s 50-day Moving Average stood at $14.30, while the 200-day Moving Average is $11.46.
Tyra Biosciences Inc (TYRA) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Tyra Biosciences Inc industry. Tyra Biosciences Inc’s current insider ownership accounts for 34.18%, in contrast to 75.20% institutional ownership. According to the most recent insider trade that took place on Nov 18 ’25, this organization’s Chief Operating Officer sold 75,633 shares at the rate of 16.07, making the entire transaction reach 1,215,627 in total value, affecting insider ownership by 220,937. Preceding that transaction, on Nov 19 ’25, Company’s Chief Operating Officer sold 49,956 for 16.32, making the whole transaction’s value amount to 815,297. This particular insider is now the holder of 170,981 in total.
Tyra Biosciences Inc (TYRA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
Tyra Biosciences Inc’s EPS decrease for this current 12-month fiscal period is -32.45% and is forecasted to reach -2.24 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -14.35% through the next 5 years, which can be compared against the -73.69% growth it accomplished over the previous five years trading on the market.
Tyra Biosciences Inc (NASDAQ: TYRA) Trading Performance Indicators
Let’s observe the current performance indicators for Tyra Biosciences Inc (TYRA). It’s Quick Ratio in the last reported quarter now stands at 17.71.
In the same vein, TYRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.88, a figure that is expected to reach -0.54 in the next quarter, and analysts are predicting that it will be -2.24 at the market close of one year from today.
Technical Analysis of Tyra Biosciences Inc (TYRA)
Now, what If we examine the latest scores posted by [Tyra Biosciences Inc, TYRA]. During the last 5-days, its volume was better the volume of 0.29 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 83.17% While, its Average True Range was 90.92.
Raw Stochastic average of Tyra Biosciences Inc (TYRA) in the period of the previous 100 days is set at 98.29%, which indicates a major rise in contrast to 97.45% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.43 that was higher than 0.79 volatility it exhibited in the past 100-days period.
